These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36965802)

  • 1. Quantitative assessment of mesothelioma and lung cancer risk based on Phase Contrast Microscopy (PCM) estimates of fibre exposure: an update of 2000 asbestos cohort data.
    Darnton L
    Environ Res; 2023 Aug; 230():114753. PubMed ID: 36965802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
    Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
    Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
    Garabrant DH; Pastula ST
    Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asbestos in the lungs of persons exposed in the USA.
    Langer AM; Nolan RP
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):168-80. PubMed ID: 9689804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
    Nicholson WJ; Raffn E
    Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden.
    Gilham C; Rake C; Burdett G; Nicholson AG; Davison L; Franchini A; Carpenter J; Hodgson J; Darnton A; Peto J
    Occup Environ Med; 2016 May; 73(5):290-9. PubMed ID: 26715106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
    Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
    Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
    Dufresne A; Harrigan M; Massé S; Bégin R
    Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study.
    Ferrante D; Mirabelli D; Silvestri S; Azzolina D; Giovannini A; Tribaudino P; Magnani C
    Am J Ind Med; 2020 Feb; 63(2):135-145. PubMed ID: 31821579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Asbestos exposure and related diseases among friction products workers (1971-2016)].
    Barbieri PG; Mirabelli D; Madeo E; Somigliana A
    G Ital Med Lav Ergon; 2020 Sep; 42(3):145-152. PubMed ID: 33119974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative relationships of exposure to chrysotile asbestos and mesothelioma mortality.
    Loomis D; Richardson DB; Elliott L
    Am J Ind Med; 2019 Jun; 62(6):471-477. PubMed ID: 31087402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibre type and concentration in the lungs of workers in an asbestos cement factory.
    Gylseth B; Mowé G; Wannag A
    Br J Ind Med; 1983 Nov; 40(4):375-9. PubMed ID: 6313034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tremolite asbestos exposures associated with the use of commercial products.
    Finley BL; Pierce JS; Phelka AD; Adams RE; Paustenbach DJ; Thuett KA; Barlow CA
    Crit Rev Toxicol; 2012 Feb; 42(2):119-46. PubMed ID: 22141364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
    Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of mesothelioma in historical context.
    McDonald JC; McDonald AD
    Eur Respir J; 1996 Sep; 9(9):1932-42. PubMed ID: 8880114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asbestos use and carcinogenicity in Germany and a comparison with animal studies.
    Pott F
    Ann Occup Hyg; 1994 Aug; 38(4):589-600, 420. PubMed ID: 7978982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.